Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...
WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...
Brooke N. Shadel , PhD, MPH, Laura A. Puzniak , PhD, MPH, Kathleen N. Gillespie , PhD, Steven J. Lawrence , MD, Marin Kollef , MD and Linda M. Mundy , MD Objective ...
Clinical isolates of Staphylococcus aureus displaying intermediate resistance to vancomycin (VISA) have been identified. The objective of our study was to identify VISA colonization among patients ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Stopping contact precautions for MRSA and ...
Please provide your email address to receive an email when new articles are posted on . Exposure to the antibiotics did not increase the risk for vancomycin-resistant Enterococcus colonization. Few ...
What Benefit Are Contact Precautions? Breaking news: Healthcare workers do not like contact precautions, and high-quality data to support contact precautions for endemic methicillin-resistant ...
A wide number of "smart" bacteria in the environment have "learned" how to resist the arsenal of antibiotics. Decades of overuse and misuse of antibiotics have caused this crisis: overzealous ...
Antibiotic exposure and dirty hands were factors linked to nursing home contamination with the multidrug-resistant bacteria vancomycin-resistant Enterococci, or VRE, a new study finds. The report was ...
BOSTON—Clinicians may want to rethink the antibiotics they prescribe for vancomycin-resistant Enterococcus (VRE) urinary tract infections (UTIs). A new retrospective study presented at the 50 th ...
Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE ...